Ftse Mib
33.635,51
1,45%
DAX
18.324,18
0,49%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
62.844,08
0,39%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aptevo Therapeutics Inc (APVO) Aptevo Therapeutics Inc (APVO) Notizie

APVO

Aptevo Therapeutics (APVO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APVO
DataOraFonteTitoloSimboloCompagnia
14/06/202422:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
10/06/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
03/06/202422:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
08/05/202414:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
05/03/202414:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
30/01/202414:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
22/12/202322:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
12/12/202322:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
01/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
22/11/202322:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
03/08/202323:21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APVOAptevo Therapeutics Inc
01/08/202322:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APVOAptevo Therapeutics Inc
02/06/202322:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APVOAptevo Therapeutics Inc
02/06/202322:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APVOAptevo Therapeutics Inc
19/04/202314:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APVOAptevo Therapeutics Inc
18/04/202314:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202314:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202322:44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202322:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APVOAptevo Therapeutics Inc
14/02/202316:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APVOAptevo Therapeutics Inc
12/12/202216:33TipRanksAptevo Skyrockets on Promising Clinical DataNASDAQ:APVOAptevo Therapeutics Inc
10/11/202214:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202214:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:APVOAptevo Therapeutics Inc
29/03/202213:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APVOAptevo Therapeutics Inc
22/11/202123:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APVOAptevo Therapeutics Inc
02/11/202114:00GlobeNewswire Inc.BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of DirectorsNASDAQ:APVOAptevo Therapeutics Inc
20/08/202112:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APVOAptevo Therapeutics Inc
11/05/202114:56Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:APVOAptevo Therapeutics Inc
28/04/202122:21Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)NASDAQ:APVOAptevo Therapeutics Inc
28/04/202122:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APVOAptevo Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APVO

La tua Cronologia

BOV
AGXY1F
Agrogalaxy Participacoes ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network